Physician Engagement And Education To Improve Reporting Of Preventable Adverse Drug Events (pADE)

RHPSNon-Specialty Specific, Past Projects

Leads/physicians involved:

  • Dr. Jane de Lemos – Clinical Pharmacist
  • Dr. Richard Chan – Emergency Medicine
  • Dr. YD You – Internal Medicine
  • Dr. Robert Mackenzie – Family Practice
  • Dr. Cheryl Nagle – Family Practice
  • Dr. Peter Ling – Internal Medicine
  • Dr. Tracy Lee – Hospitalist

Working group meetings:

  • April 3, 2019
  • May 9, 2019
  • July 26, 2019
  • August 1, 2019
  • October 30, 2019

Current status of project:

  • Completed pADE reporting tool and go-live at Richmond Hospital in October 2019
  • Formal completion of pADE project December 2019
  • Richmond Hospital pADE Program now established – ongoing surveillance and reporting of pADEs via reporting tool
  • Submission of pADE project outcomes for publishing in medical journals – ongoing
  • Sharing of learnings from pADE project to other hospitals and health authorities – ongoing

Engagement:

  • Richmond Division of Family Practice – pADE presentation at CME Clinical Pearls Event on June 4, 2019
  • Roll out of Richmond Hospital pADE Program including pADE reporting tool (October to December 2019) – consisted of presentations to target groups including hospital pharmacists, community pharmacists, geriatric/ED/transition RNs, and emergency, hospitalist, and internal medicine physicians
  • Richmond Hospital Physician Society – lunch hour project showcase on Sep. 19, 2019
  • CME dinner event with ED RNs, geriatric emergency RNs, chronic care and transition RNs, and over 45 community pharmacists on November 27, 2019

Benefits of pADE project:

  • Reduction of preventable adverse drug events leading to emergency department visits and hospital admissions
  • Ongoing surveillance and reporting of pADEs to prescribing clinicians
  • pADE education materials produced and available for patients/families and prescribers
  • Patient and family education provided by pharmacy and hospital staff when pADE identified and reported